Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Premier Health of America Inc T.PSN


Primary Symbol: V.PHA Alternate Symbol(s):  PRHAF

Premier Health of America Inc. is a Canadian healthtech company. The Company provides a comprehensive range of outsourced service solutions for healthcare needs to governments, corporations, and individuals. The Company uses its proprietary LiPHe platform to lead the healthcare services sector in digital transformation to provide patients with more accessible care services. The Company operates through two segments: Per Diem and Travel Nurses. The Per Diem segment includes Premier Soin and Code Bleu, two of its Quebec subsidiaries that offer their respective services for nursing and assistance by profile and by region. The Travel nurse segment includes Canadian Health Care Agency, Premier Soin Nordik, Solutions Nursing as well as Solutions Staffing, four of its subsidiaries that offer their respective services to the federal and provincial governments for nursing and assistance, including in remote regions.


TSXV:PHA - Post by User

Post by scissors14on Nov 15, 2012 11:36am
466 Views
Post# 20604713

Scotia Target Lowered To $11

Scotia Target Lowered To $11

Poseidon Concepts Corp.
(PSN-T C$13.22)
Huge Q3 Miss Overshadows New Products Launch
Vladislav C. Vlad, MBA, P.Eng. - (403) 213-7759
(Scotia Capital Inc. - Canada)
vladislav.vlad@scotiabank.com
Sam Devlin - (403) 213-7332
(Scotia Capital Inc. - Canada)
sam.devlin@scotiabank.com
Div. (NTM)
$1.08
Div. (Curr.)
$1.08
Yield (Curr.)
8.2%
Rating: 3-Sector Underperform
Target
1-Yr:
C$11.00
ROR
1-Yr:
-8.6%
Risk Ranking: High
Valuation: 7.2x our 2013 EV/EBITDA estimate.
Key Risks to Target: Commodity prices, labour supply, access to supplies, weather, contract risk, and FX.
Event
¦
Q3 EBITDA of $26.6M was 53% below our $56.6M estimate and consensus of $57.3M due to substantially lower than anticipated utilization, which impacted pricing and margins in all operating areas. Following the results, an analyst meeting was held at PSN's office.
Implications
¦
Management lowers 2012 EBITDA guidance to $145M (midpoint), down 31%. We cut our 2013 EBITDA estimates to $127M (-53%) on a 44% reduction in operating time and roughly 15% lower pricing YOY. Management also trimmed 2012 spending to $35M (from $60M), as tank construction was curtailed at the end of August to 440 tanks.
¦
New product suite strengthens PSN's market position; "pull" customer response is encouraging but will take time to build to scale. Management's ability to innovate continues with the rollout of in-tank heaters, remote fluid monitoring, and water transfer solutions. We model $15M of revenue from non-tank rentals in 2013 @ 70% margin.
Recommendation
¦
Our price target reduces to $11 (from $20). We downgrade PSN to 3-SU from 1-SO and are of the view the dividend is sustainable. PSN's attractive yield should act as a support for the stock. The board approved a DRIP, subject to TSX approval. We forecast 2013E FCF of $100M and ~$65M in cash dividends, under a 30% DRIP participation rate; excluding DRIP participation, cash dividends would be roughly $90M.
Pertinent Revisions
New
Old
Rating:
3-SU
1-SO
Target:
1-Yr
$11.00
$20.00
EBITDA12E
$143
$214
EBITDA13E
$127
$268
New Valuation:
7.2x our 2013 EV/EBITDA estimate.
Old Valuation: 6.0x our 2013 EV/EBITDA estimate.
Qtly EBITDA (M)
Q1
Q2
Q3
Q4
Year
EV / EBITDA
2010A
2011A
$9 A
$7 A
$20 A
$28 A
$65
16.1x
2012E
$44 A
$46 A
$27 A
$27
$143
7.9x
2013E
$35
$29
$31
$31
$127
8.8x
(FY-Dec.)
2009A
2010A
2011A
2012E
2013E
Cash Flow/Share
$1.24
$1.58
$1.42
Gross Margin
87.8%
86.4%
79.4%
IBES CFPS 2012E: $2.05
Curr. BVPS
$1.22
IBES CFPS 2013E: $2.63
ROE12E
160.04%
Historical price multiple calculations use FYE prices. Source: Reuters; company reports; Scotiabank GBM estimates.
All values in C$ unless otherwise indicated.

Bullboard Posts